These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7720832)

  • 21. Prognostic significance of magnetic resonance imaging of bone marrow in previously untreated patients with multiple myeloma.
    Moulopoulos LA; Gika D; Anagnostopoulos A; Delasalle K; Weber D; Alexanian R; Dimopoulos MA
    Ann Oncol; 2005 Nov; 16(11):1824-8. PubMed ID: 16087694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Comparison of Different Staging Systems for Multiple Myeloma: Can the MRI Pattern Play a Prognostic Role?
    Filonzi G; Mancuso K; Zamagni E; Nanni C; Spinnato P; Cavo M; Fanti S; Salizzoni E; Bazzocchi A
    AJR Am J Roentgenol; 2017 Jul; 209(1):152-158. PubMed ID: 28418695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Long-term survival and prognostic factors in stage II-III multiple myeloma treated with conventional chemotherapy].
    Pertuiset E; Chevret S; Lioté F; Delauche MC; Bardin T; Dryll A; Kuntz D
    Ann Med Interne (Paris); 1992; 143(8):519-24. PubMed ID: 1303595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic criteria and histologic grading in multiple myeloma: histologic and immunohistologic analysis of 176 cases with clinical correlation.
    Sukpanichnant S; Cousar JB; Leelasiri A; Graber SE; Greer JP; Collins RD
    Hum Pathol; 1994 Mar; 25(3):308-18. PubMed ID: 8150462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone marrow angiogenesis and its correlation with other disease characteristics in multiple myeloma in stage I versus stage II-III.
    Niemöller K; Jakob C; Heider U; Zavrski I; Eucker J; Kaufmann O; Possinger K; Sezer O
    J Cancer Res Clin Oncol; 2003 Apr; 129(4):234-8. PubMed ID: 12700896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined evaluation of bone marrow aspirate and biopsy is superior in the prognosis of multiple myeloma.
    Stifter S; Babarović E; Valković T; Seili-Bekafigo I; Stemberger C; Nacinović A; Lucin K; Jonjić N
    Diagn Pathol; 2010 May; 5():30. PubMed ID: 20482792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of myeloma cells by means of labeling index, bone marrow histology, and serum beta 2-microglobulin.
    Schambeck CM; Bartl R; Höchtlen-Vollmar W; Wick M; Lamerz R; Fateh-Moghadam A
    Am J Clin Pathol; 1996 Jul; 106(1):64-8. PubMed ID: 8701935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prognostic soundness of the cytologic and histologic examination of the bone marrow in myeloma].
    Bettini R; Rapazzini P; Ferrari V; Ambruzzi AM; Mascalzi MG; Steidl L
    Recenti Prog Med; 1986; 77(7-8):357-61. PubMed ID: 3786936
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparative study of fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for the detection of spinal bone marrow infiltration in untreated patients with multiple myeloma.
    Hur J; Yoon CS; Ryu YH; Yun MJ; Suh JS
    Acta Radiol; 2008 May; 49(4):427-35. PubMed ID: 18415787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The diagnosis of multiple myeloma].
    Bartl R; Fateh-Moghadam A
    Onkologie; 1986 Aug; 9(4):183-8, 190-5. PubMed ID: 3531945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stage III multiple myeloma: clinical and prognostic value of spinal bone marrow MR imaging.
    Lecouvet FE; Vande Berg BC; Michaux L; Malghem J; Maldague BE; Jamart J; Ferrant A; Michaux JL
    Radiology; 1998 Dec; 209(3):653-60. PubMed ID: 9844655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histologic classification and staging of multiple myeloma. A retrospective and prospective study of 674 cases.
    Bartl R; Frisch B; Fateh-Moghadam A; Kettner G; Jaeger K; Sommerfeld W
    Am J Clin Pathol; 1987 Mar; 87(3):342-55. PubMed ID: 3825999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histology and immunohistology of bone marrow biopsy in multiple myeloma.
    Pileri S; Poggi S; Baglioni P; Montanari M; Sabattini E; Galieni P; Tazzari PL; Gobbi M; Cavo M; Falini B
    Eur J Haematol Suppl; 1989; 51():52-9. PubMed ID: 2627992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of MRI for the diagnosis and prognosis of multiple myeloma.
    Baur-Melnyk A; Buhmann S; Dürr HR; Reiser M
    Eur J Radiol; 2005 Jul; 55(1):56-63. PubMed ID: 15950101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic and prognostic value of the MB2 monoclonal antibody in paraffin-embedded bone marrow sections of patients with multiple myeloma and monoclonal gammopathy of undetermined significance.
    Dehou MF; Schots R; Lacor P; Arras N; Verhavert P; Klöppel G; van Camp B
    Am J Clin Pathol; 1990 Sep; 94(3):287-91. PubMed ID: 1697732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of plasma cell morphology in multiple myeloma.
    Carter A; Hocherman I; Linn S; Cohen Y; Tatarsky I
    Cancer; 1987 Sep; 60(5):1060-5. PubMed ID: 3607725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of criteria in staging in multiple myeloma.
    Pennec Y; Mottier D; Youinou P; Asselain B; Miossec P; Le Goff P; Le Prise PY; Le Menn G
    Haematologia (Budap); 1982; 15(2):221-6. PubMed ID: 7160667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic relevance of morphological classification in multiple myeloma.
    Murakami H; Nemoto K; Sawamura M; Tamura J; Matsushima T; Naruse T; Tsuchiya J; Sato S; Shiamano S; Shinonome S
    Acta Haematol; 1992; 87(3):113-7. PubMed ID: 1642091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Role of
    Deng S; Zhang B; Zhou Y; Xu X; Li J; Sang S; Zhang W
    Contrast Media Mol Imaging; 2018; 2018():4198673. PubMed ID: 30154686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation Between Baseline 18F-FDG PET/CT Findings and CD38- and CD138-Expressing Myeloma Cells in Bone Marrow and Clinical Parameters in Patients with Multiple Myeloma.
    Cengiz A; Arda HÜ; Döğer F; Yavaşoğlu İ; Yürekli Y; Bolaman AZ
    Turk J Haematol; 2018 Aug; 35(3):175-180. PubMed ID: 29806594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.